NCT06522633View on ClinicalTrials.gov

Esophageal Dysfunction Associated With Opioids: Clinical Response and Manometric Findings After Opioid Discontinuation

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

February 1, 2024

Study Completion Date

August 31, 2024

Conditions
Opioid Use
Interventions
DRUG

The intervention involves the discontinuation of the opioid.

Patients with dysphagia and esophageal manometry indicating opioid-induced esophageal dysfunction (OIED) will have the opioid discontinued, and esophageal manometry will be repeated.

Trial Locations (1)

08036

Hospital Clínic of Barcelona, Barcelona

All Listed Sponsors
collaborator

Vall Hebron Insitut Recerca

NETWORK

lead

Hospital Clinic of Barcelona

OTHER

NCT06522633 - Esophageal Dysfunction Associated With Opioids: Clinical Response and Manometric Findings After Opioid Discontinuation | Biotech Hunter | Biotech Hunter